Oncology
2301 articles · 70 journals
Journals in this subcategory (70)
- Blood Neoplasia · Elsevier (95)
- European Journal of Surgical Oncology · Elsevier (90)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- Cancer Treatment and Research Communications · Elsevier (88)
- The Lancet Oncology · Elsevier (88)
- Brachytherapy · Elsevier (86)
- Cancer Epidemiology · Elsevier (85)
- International Journal of Gynecological Cancer · Elsevier (83)
- Journal of Thoracic Oncology · Elsevier (82)
- EJC Skin Cancer · Elsevier (81)
- Lung Cancer · Elsevier (73)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Critical Reviews in Oncology/Hematology · Elsevier (69)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (64)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (63)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (59)
- Blood Reviews · Elsevier (54)
- Cancer Letters · Elsevier (53)
- Journal of the National Cancer Center · Elsevier (53)
- Leukemia Research · Elsevier (52)
- The Journal of Liquid Biopsy · Elsevier (52)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (40)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (20)
- Intelligent Oncology · Elsevier (19)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Adaptive Feedback Signaling Through the FAK/SRC Pathway Promotes KRAS G12C Inhibitor Resistance
- Weight Gain on Lorlatinib Is Associated With Accumulation of Visceral Adipose Tissue
- Genomic Landscape and Clinical Impact of MTAP Loss in Driver-Positive NSCLC: Insights From a Large-Scale Real-World Chinese Cohort
- Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in NSCLC
- Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial
- Phase III Study of Niraparib Plus Pembrolizumab as Maintenance Therapy for Advanced or Metastatic NSCLC (ZEAL-1L)
- Patient selection for local consolidative therapy in advanced non-small cell lung cancer after first line systemic therapy: a prospective study
- RNF5-DNAJA1 axis dictates selinexor sensitivity of multiple myeloma by regulating mitochondrial unfolded protein response
- Amivantamab Induces Immune-Mediated Cytotoxicity in Mesothelioma Through EGFR and MET Engagement
- Neuronal hijacking of cancer niches: integration, remodeling, evolution
- Comparative efficacy of Chinese-developed versus imported PD-1/PD-L1 inhibitors in first-line combination therapy for advanced NSCLC: a systematic review and network meta-analysis
- The Prognostic Impact of Common Molecular Alterations in Resected Lung Adenocarcinoma and Implications for the Tenth Edition TNM Classification
- Brief Report: Aumolertinib as a Switch Therapy in Osimertinib-Intolerant NSCLC—The ACTIVE Trial
- Systemic inflammatory protein signatures associated with gastric lesion progression and risk of gastric cancer
- Refining the Prognostic Meaning of MTAP Loss in Driver-Positive NSCLC
- Cancer innervation: from mechanisms to clinical implications
- A Response to the Letter to the Editor: “Refining the Prognostic Meaning of MTAP Loss in Driver-Positive NSCLC”
- Central Adiposity, Confounding Medications, and the Reinterpretation of the “Obesity Paradox” in Lung Cancer Risk
- A Response to the Letter to the Editor: “Central Adiposity, Confounding Medications, and the Reinterpretation of the “Obesity Paradox” in Lung Cancer Risk”
- Global patterns and trends in colon cancer incidence by anatomical subsite in 2022: a population-based study
- CDK13 phosphorylates KDM2A to activate a NUP93–STAT3–HMGCR cascade that promotes PDAC metastasis via cholesterol biosynthesis
- A Three-Month Washout Is a Risk Marker, Not a Safety Threshold, Before Adjuvant Osimertinib
- Response to the Letter
- Epstein–Barr virus (EBV)–associated lung carcinoma
- Biological time and occupational leukemogenesis: the circadian rhythm as a cofactor in benzene toxicity
- Accelerating the clinical translation of bioengineered anticancer therapeutics
- Should we optimise or revise the management of initially unresectable stage III non-small cell lung cancer: rethinking consolidation therapy
- Technical review of artificial intelligence in TCR-T therapy
- Brief Report: Patterns of Disease Progression with Durvalumab versus Placebo After Concurrent Chemoradiotherapy for Limited-Stage SCLC in the Phase 3 ADRIATIC Trial
- Tarlatamab for Treatment of Small Cell Lung Cancer in Clinical Practice: A Multicenter U.S. Retrospective Cohort Study from the ONWARD consortium